These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11150878

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary.
    Griffiths AP, Cross D, Kingston RE, Harkin P, Wells M, Quirke P.
    Int J Gynecol Pathol; 1993 Oct; 12(4):307-14. PubMed ID: 8253547
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of nucleolar organizer regions in ovarian epithelial tumors.
    Criscuolo M, Martinelli AM, Migaldi M, Zunarelli E, Bergamaschi M, Falchi AM, De Gaetani C.
    Int J Gynecol Pathol; 1993 Jul; 12(3):259-63. PubMed ID: 8344763
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Argyrophilic nucleolar organizer region counts in exocrine pancreatic tumors.
    Ohta T, Nagakawa T, Tsukioka Y, Mori K, Kayahara M, Kanno M, Ueno K, Miyazaki I, Terada T, Nakanuma Y.
    Int J Pancreatol; 1992 Dec; 12(3):201-9. PubMed ID: 1337756
    [Abstract] [Full Text] [Related]

  • 8. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
    Stemberger-Papić S, Stanković T, Vrdoljak-Mozetic D, Versa-Ostojić D, Krasević M, Stifter S, Audy-Jurković S.
    Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
    Ghazizadeh M, Sasaki Y, Araki T, Konishi H, Aihara K.
    Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Usefulness of argyrophilic nucleolar organizer staining for predicting prognosis of patients with recurrent soft tissue sarcoma.
    Kuratsu S, Ohsawa M, Naka N, Myoui A, Tomita Y, Uchida A, Ono K, Aozasa K.
    Oncology; 1994 Apr; 51(3):244-50. PubMed ID: 8196907
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence.
    Kunishio K, Ohmoto T, Matsuhisa T, Maeshiro T, Furuta T, Matsumoto K.
    Cancer; 1994 Apr 15; 73(8):2200-5. PubMed ID: 8156526
    [Abstract] [Full Text] [Related]

  • 17. Argyrophilic nucleolar organizer region (AgNOR) counting in astrocytic gliomas: prognostic value.
    Ferreres JC, Figols J, Val-Bernal JF, Cardesa A, Cruz Sánchez FF.
    Histol Histopathol; 1996 Jan 15; 11(1):35-9. PubMed ID: 8720446
    [Abstract] [Full Text] [Related]

  • 18. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
    Derenzini M, Trerè D.
    Pathologica; 2001 Apr 15; 93(2):99-105. PubMed ID: 11428299
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.